






























Sirtuins are NAD+-dependent protein deacetylases 
regulating metabolism and aging processes, and they 
were suggested to mediate lifespan extending effects of 
caloric restriction [1, 2]. Sirtuin activation through the 
polyphenol resveratrol can mimic such effects in yeast 
and higher organisms, and Sirt1 activation can alleviate 
metabolic diseases in mice [3-5]. Sirtuin activation by 
resveratrol and other compounds is controversially 
debated [6, 7], since stimulation of mammalian Sirt1 
against the widely used “Fluor-de-Lys” substrate [3] 
depended on the presence of a non-physiological 
fluorophor that replaces the peptide chain immediately 
C-terminal to the acetyllysine [8, 9]. However, a large 
body of work indicates Sirt1-dependent resveratrol 
effects [10-12], and peptide sequences terminating with 
the acetyllysine do not well represent physiological 
substrate sites.  
 
To test whether physiological deacetylation sites can 
respond to resveratrol-dependent Sirt1 activation, we 
employed a mammalian acetylome microarray system. 
It enables parallel assays on 6802 physiologically 
occurring   acetylation  sites,   represented  by  13-meric  
 
 






























peptides with the acetyllysine at the center (Rauh et al., 
submitted). Sirt1-dependent deacetylation of the 
microarray peptides was tested in presence and absence 
of 200 μM resveratrol. Comparing basal deacetylation 
to the reaction in presence of the compound revealed 
different outcomes for different substrates (Figure 1A). 
While deacetylation in presence of resveratrol was 
significantly increased for some peptides, the majority 
of sequences showed no or only small changes in 
deacetylation. Deacetylation of another smaller set of 
peptides was strongly inhibited.  
 
The substrate sequence-dependent effect would explain 
why resveratrol has Sir2-dependent effects in C. elegans 
overlapping with, but not identical to, the effects of Sir2 
overexpression [13], and why resveratrol failed to 
stimulate Sirt1 against some substrates [14, 15]. To 
validate the influence of substrate sequence, we selected 
peptides representing nuclear deacetylation sites from 
the groups with increased, unchanged, and inhibited 
deacetylation in presence of resveratrol. Testing Sirt1-
dependent deacetylation of these non-modified, 
acetylated peptides using mass spectrometry confirmed 















Abstract: Sirtuins  are  protein  deacetylases  used  as  therapeutic  targets.  Pharmacological  Sirt1  activation  has  been
questioned since the in vitro activator resveratrol failed to stimulate deacetylation of several physiological substrates. We
tested  the  influence  of  substrate  sequence  by  analyzing  resveratrol  effects  on  Sirt1‐dependent  deacetylation  of  6802
physiological acetylation sites using peptide microarrays. Resveratrol stimulated deacetylation of a small set of sites and
inhibited deacetylation of another  set, whereas most  substrates were hardly affected. Solution assays  confirmed  these
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our conclusion (Figure 1B). Deacetylation of a splicing 
factor 38A (SF38A)-K23 peptide was activated, 
deacetylation of a DEAD box protein 3 (DDX3X)-K118 
peptide remained unchanged, and deacetylation of a 
histone H3-K116 peptide was inhibited. Activation of 
SF38A-K23 deacetylation was stimulated with an EC50 
of 22±16 μM (Figure 1C), comparable to the potency of 
resveratrol against Sirt1 in the FdL assay (EC50~50-100 
μM) [3]. 
 
The array results indicate Sirt1 substrates whose 
changed deacetylation might contribute to physiological 
resveratrol effects: Deacetylation is, e.g., increased for 
FOXO4-K189 and protein acetyltransferase p300-K489, 
and decreased for Ku 70-K539 and estrogen receptor 
alpha-K303. To reveal substrate sequence requirements 
for resveratrol-dependent activation or inhibition of 
deacetylation, we statistically analyzed the differently 




































at each peptide position, compared to the overall 
occurrence on the microarray (Figure 1D). There is a 
preference for large, mainly hydrophobic residues at 
several positions C-terminal to the acetyllysine in 
substrates whose deacetylation can be stimulated, 
whereas positively charged residues are disfavored in 
most positions. For inhibition, hydrophilic residues 
seem preferential N-terminal and polar and negatively 
charged residues C-terminal from the acetyllysine.  
 
We identified fluorophor-free, physiological substrate 
sites whose deacetylation can be stimulated by 
resveratrol. Our results suggest Sirt1 targets 
contributing to physiological resveratrol effects and the 
revealed substrate sequence dependent outcome 
indicates that Sirt1 inhibition should also be involved. 
Excitingly, these findings reveal the possibility to 
develop drugs modulating Sirt1-dependent deacetylation 



































Figure  1.  Activation  of  Sirt1  by  resveratrol  is  substrate  sequence‐selective.  (A)  Sirt1‐dependent





either activated or  inhibited  through  resveratrol. The acetyllysine  is  in  the center,  residues on  top are  favored,
residues at the bottom disfavored when compared to their overall frequency at this position. 
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MATERIALS AND METHODS 
 
Chemicals. All chemicals were obtained from Sigma 
(Saint Louis, USA) if not stated differently. Peptides for 
assays were purchased HPLC purified with unmodified 
N- and C-terminus from GL Biochem: SF38A-K23, 
PQYLVE(acetylK)IIRTRI; DDX3X, DRSGFG(acetylK) 
FERGGN; Histone H3-K116, IHA(acetylK)RVT. 
 
Cloning, recombinant expression, and purification of 
Sirt1. Full-length human Sirt1 was cloned into pET15b, 
resulting in constructs with N-terminal his-tag, and 
verified by DNA-sequencing. Sirt1 protein was 
prepared as described [16]. Briefly, protein was 
expressed in E. coli Rosetta 2(DE3) cells lysed in buffer 
A (50 mM Tris, pH 7.5, 300 mM NaCl and 10 mM 
imidazole), and protein bound to Talon resin (Clontech, 
Mountain View, USA). The resin was washed with 
buffer A. Protein was eluted with buffer A + 200 mM 
imidazol, subjected to gel filtration on a Superdex200 
column (GE Healthcare) in 25 mM HEPES, pH 7.5, 100 
mM KCl, 2 mM DTT, concentrated in amicon units 
(Millipore), and stored at -80°C. 
 
Microarray experiments. Acetylome peptide micro-
arrays were manufactured as described (Rauh et al., 
submitted). Shortly, peptides were synthesized on 
cellulose membranes using parallel SPOT synthesis 
[17]. Peptides were cleaved from membranes with 
aqueous triethylamine (2.5 % v/v), solvent evaporated, 
and peptides re-dissolved in printing solution (70% 
DMSO, 25% 0.2 M sodium acetate pH 4.5, 5 % glycerol 
v/v). Peptides were printed on epoxy modified slides 
(PolyAn), quenched, washed, dried, and stored at 4 °C. 
 
For deacetylation experiments, microarrays were treated 
2 h with 20 µg/ml Sirt1 in reaction buffer (25 mM 
HEPES, pH 7.5, 100 mM KCl, 2 mM dithioerythrol, 3% 
bovine serum albumin , 1 mM NAD+) in presence or 
absence of 200 μM resveratrol, washed, and dried. In a 
hybridization station (HS400, Tecan) at 25 °C, arrays 
were washed several times, incubated 1 h with three 
primary antibodies (0.2 µg/ml mouse mAb 7F8 
[Abcam],  0.2 µg/ml mouse mAb AcK103 [CST],  0.2 
µg/ml rabbit mAb AcK2-100 [CST]) and washed. After 
incubation with two secondary fluorescence labeled 
antibodies (0.5 µg/ml Goat IgG Dylight 649 anti mouse 
and anti rabbit, respectively [Thermo Scientific]) for 30 
min, microarrays were washed, dried, and scanned at 10 
nm resolution using a Genepix Scanner 4000B 
(Molecular Devices) and a 635 nm laser. Spot 
recognition was done using Genepix Pro 7.0 (Molecular 
Devices). Data processing was done in GNU R 
(http://www.r-project.org/). Sequence feature logos 
were created using TwoSampleLogo [18]. 
Mass spectrometry deacetylation assays. Assays 
containing 50 μM NAD+, 5 μM peptide, and 25-200 
nM Sirt1 were incubated in 25 mM HEPES, pH 7.5 at 
37 °C, aliquots stopped after different time points by 
adding formic acid, and substrate and product quantified 
by liquid chromatography coupled mass spectrometry 
[19]. For stimulation, 1 % (v/v) DMSO (control 
samples) or 100 μM resveratrol was added. Resveratrol 
titration was done analogous with DMSO kept at 1 % 
(v/v), but with 500 μM NAD+ at 25 ºC. Deacetylation 
speed or product levels after 30 min were determined 
from linear fits to time series, and data shown are 
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The Supplementary Table - Sirt1-dependent deacetyla-
tion of microarray peptides in presence and absence of 
resveratrol - is found in full text version of this 
manuscript. The numbers correspond to the ratios of 
residual acetylation signals after Sirt1 treatment in 
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